Shockwave Medical (SWAV) 10-Q2023 Q2 Quarterly report

Filed: 7 Aug 23, 4:46pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: abandonment, accommodate, adequate, amortizable, apply, ASC, assembled, assigned, assumed, award, bare, breath, budget, Bunker, buyer, card, cardiology, chest, comparison, comprised, consummated, CVR, debilitating, deductible, deemed, defense, Director, enterprise, equivalent, European, exercise, exercised, expiration, expire, extension, failed, failure, finite, forma, frequently, Godshall, goodwill, Hill, indefinite, independent, intangible, investigation, Laura, life, longer, maximum, member, metal, milestone, month, movement, muscle, open, pain, painful, pattern, Plant, population, practical, preliminary, premarket, pro, provisional, recoverability, recoverable, reevaluate, refractory, relief, remeasure, residual, resistant, revascularization, screen, steel, stipulated, suffering, Taiwan, tangible, test, tested, testing, threshold, timeline, undiscounted, Union, unknown, unobservable, warrant, whichever, window, workforce, written

Removed: Breakthrough, build, crack, Designation, manufacturer, negatively, pandemic, payable, response, treated

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated SWAV transcripts

SWAV similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Shockwave Medical, Inc. (the “Company”) on Form 10-Q for the period ending June 30, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 7, 2023


By:						/s/ Douglas Godshall
						Douglas Godshall
						President, Chief Executive Officer and Director (Principal Executive Officer)